Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
28 hedge funds and large institutions have $47.7M invested in Global Cord Blood Corporation in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
10% less funds holding
Funds holding: 31 → 28 (-3)
26% less capital invested
Capital invested by funds: $64.4M → $47.7M (-$16.7M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
76% less call options, than puts
Call options by funds: $50K | Put options by funds: $211K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$1.57M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$412K |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$237K |
| 4 |
Barclays
London,
United Kingdom
|
+$117K |
| 5 |
Man Group
London,
United Kingdom
|
+$84.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$8.57M |
| 2 |
Renaissance Technologies
New York
|
-$1.45M |
| 3 |
SG Americas Securities
New York
|
-$679K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$391K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$196K |
CO Hedge Fund Activity: Q3 2021 in Review
28 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2021, worth a combined $47.7M — down 26% from $64.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CO and 3 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 9 added.
The largest buyer was Oasis Management Company, adding an estimated $1.57M. The largest seller was BlueCrest Capital Management, cutting an estimated $8.57M.
- 28 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2021, down from 31 in Q2 2021.
- Funds reported $47.7M of Global Cord Blood Corporation stock for Q3 2021, down 26% quarter-over-quarter.
- 3 funds opened new Global Cord Blood Corporation positions in Q3 2021 and 6 closed out, a net change of -3 holders.
- The largest Global Cord Blood Corporation buyer in Q3 2021 was Oasis Management Company, an estimated $1.57M added.
- The largest Global Cord Blood Corporation seller in Q3 2021 was BlueCrest Capital Management, an estimated $8.57M sold.
Based on aggregated 13F filings for Q3 2021.